NDATOPICALSOLUTION
Lifecycle
Pre-Launch
Clinical Trials
1
Data completeness
1/8 — Limited
Drug data last refreshed 17h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DYCLONE (dyclonine hydrochloride) is a topical local anesthetic solution in pre-launch development by AstraZeneca. The drug's specific mechanism of action and indicated therapeutic use are not yet publicly detailed. It is formulated as a topical solution for dermal or mucosal application.
Pre-Launch
Pre-launch phase offers opportunity to join a product team building market infrastructure and commercial strategy, with team expansion likely pending regulatory approval.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Ondansetron Combined with Dyclonine Hydrochloride to Improve Patient Experience in Unsedated Esophagogastro-duodenoscopy
Started Jan 2025
260 enrolled
Esophagogastroduodensocopy (EGD) Procedure
Career Relevance
DYCLONE is in pre-launch phase with no active job postings linked to the product, indicating the team is likely being assembled or integrated within AstraZeneca's broader dermatology or topical anesthetic portfolio. Joining this product offers ground-floor opportunity to shape commercial strategy and market entry, though career trajectory depends critically on regulatory approval and competitive differentiation.
Brand Manager
Worked on DYCLONE at AstraZeneca? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.